Navigation Links
FDA Says Tessalon Liquid Cough Capsules Pose Risk for Young Children
Date:12/14/2010

SILVER SPRING, Md., Dec. 14, 2010 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration is warning that accidental ingestion of Tessalon (benzonatate) by children younger than 10 years can result in serious side effects or death.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

Tessalon, approved by the FDA to treat symptomatic relief of cough in patients older than 10, may attract younger children because of the drug's candy-like appearance – a round, liquid-filled gelatin capsule. The safety and effectiveness of benzonatate in children younger than 10 years has not been established.

"Benzonatate should be kept in a child-resistant container and stored out of reach of children," said Carol Holquist, R.Ph., director of FDA's Division of Medication Error Prevention and Analysis. "The FDA encourages health care professionals to talk with their patients and those caring for children about the risk of accidental ingestion or overdose."

A review of the FDA's Adverse Event Reporting System database from 1982 through May 2010 identified seven cases of accidental ingestion associated with benzonatate in children younger than 10. Five of the cases resulted in death in children ages 2 years and younger. Overdose with benzonatate in children younger than 2 years has been reported following accidental ingestion of only one or two benzonatate capsules.

Common adverse events reported in the overdose cases included cardiac arrest, coma, and convulsion. Signs and symptoms of overdose can occur within 15-20 minutes of ingestion. Some of the deaths reported in children have been within hours of the accidental ingestion.  

The FDA is also adding a new Warning and Precaution section to the benzonatate drug label to warn health care professionals about accidental ingestion resulting in overdose and death in children younger than 10.

Consumers and health care professionals are encouraged to report adverse side effects or medication errors from the use of benzonatate to the FDA's MedWatch Adverse Event Reporting program at www.fda.gov/MedWatch or by calling 800-332-1088.

For more information:

FDA 101: Medication Errors

http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm048644.htm

Media Inquiries: Shelly Burgess, 301-796-4651, shelly.burgess@fda.hhs.gov

Consumer Inquiries: 888-INFO-FDA


'/>"/>
SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Innovative Clinical Solutions, Ltd. Announces Second and Final Liquidating Cash Distribution
2. AccuDial® Pharmaceutical Solves OTC Dosing Errors for Childrens Liquid Medications
3. American Oriental Bioengineering Introduces Wujia Rongxue Oral Liquid
4. NeurogesX Doses First Patient in Phase 2 Clinical Study of NGX-1998 Liquid Capsaicin Formulation
5. AMS Announces Worldwide Launch of the Revolutionary MoXy™ Liquid Cooled Fiber for Fast, Safe Treatment of Enlarged Prostate
6. Instrumentation Laboratory Introduces Fully Automated, Liquid, Ready-to-Use HemosIL® HIT-Ab(PF4-H) Assay in Europe
7. AMS Receives 510(k) Clearance of Its Revolutionary MoXy(TM) Liquid Cooled Fiber for Fast, Safe Treatment of Enlarged Prostate
8. University HealthSystem Consortium Selects Centurion Service Group for Equipment and Asset Liquidation Services
9. Renhuang Pharmaceuticals Announces Plans to Introduce Qing Re Jie Du Oral Liquid
10. Caliper Life Sciences Introduces Sciclone(R) G3 Liquid Handler
11. Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... CARLSBAD, Calif. , July 10, 2017  The ... in Boston, MA at the ... unequaled value and unparalleled access to global decision makers ... to draw 800+ life science leaders during two impactful ... Boston, and provides delegates with additional networking opportunities with ...
(Date:7/6/2017)... , July 6, 2017 ThriveRx, the nutrition division of ... their families to thrive on nutrition support. To celebrate its ... new site has a fresh new look with improved organization to create ... ... ...
(Date:7/5/2017)... JERUSALEM , July 5, 2017 ... www.oramed.com ), a clinical-stage pharmaceutical company ... today that it has received approval from the Israel Securities ... Stock Exchange (TASE). Oramed common stock will commence trading on ... Based on the current market capitalization of the Company, it ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... ... to renovate and improve the Ramsey County Medical Examiners Facility located in Saint ... the $2.5 million project is scheduled to start in late 2017/early 2018. ...
(Date:7/21/2017)... ... ... Bernard R. Bach, Jr., MD, orthopaedic surgeon at Rush University Medical Center ... Medicine (AOSSM) , received the 2017 Robert E. Leach Sports Medicine Leadership award on ... award is given annually to honor those who have made a significant contribution to ...
(Date:7/21/2017)... ... 21, 2017 , ... MedMatchPlus+ has launched a residency application ... a residency in a United States hospital. Being accepted into a residency is ... to data released by the ECFMG®, every year, 50 percent of international medical ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the first ... the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related functions ... activity levels decline over time. The study, presented today at the American ...
(Date:7/20/2017)... ... July 20, 2017 , ... ChenMed , a leading provider of value-based ... Medical Center as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor ... Medical Officer of Ambulatory Services for the UVA Health System, brings 30 years of ...
Breaking Medicine News(10 mins):